We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $5.89B
1-Year Est. Return 28.74%
This Fund
S&P 500
This Quarter Est. Return
+37.58%
1 Year Est. Return
+28.74%
3 Year Est. Return
+88.57%
5 Year Est. Return
+106.57%
10 Year Est. Return
+590.49%
AUM
$10.5B
AUM Growth
+$2.1B
Cap. Flow
-$429M
Cap. Flow %
-4.09%
Top 10 Hldgs %
13.09%
Holding
245
New
23
Increased
75
Reduced
125
Closed
18

Top Buys

Rank Stock Value
1
NEWR
New Relic, Inc.
NEWR
+$64.1M
2
BILL icon
BILL Holdings
BILL
+$53.1M
3
IMMU
Immunomedics Inc
IMMU
+$52.9M
4
ATRC icon
AtriCure
ATRC
+$51.2M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$49.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$120M
2
CBRE icon
CBRE Group
CBRE
+$89.6M
3
CHGG icon
Chegg
CHGG
+$66M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.2M
5
DOX icon
Amdocs
DOX
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 29.58%
2 Healthcare 18.33%
3 Industrials 14.56%
4 Consumer Discretionary 9.8%
5 Financials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNR icon
1
RenaissanceRe
RNR
$13.9B
$209M 2%
1,223,655
+82,955
+7% +$13.6M
PGR icon
2
Progressive
PGR
$128B
$146M 1.39%
1,819,200
-189,050
-9% -$14.8M
SBAC icon
3
SBA Communications
SBAC
$18.9B
$143M 1.36%
479,077
+25,290
+6% +$7.46M
ZNGA
4
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$139M 1.32%
14,548,100
-1,536,500
-10% -$12.6M
GPN icon
5
Global Payments
GPN
$24.2B
$132M 1.26%
780,057
+28,982
+4% +$4.82M
BAH icon
6
Booz Allen Hamilton
BAH
$8.44B
$129M 1.23%
1,657,405
-270,900
-14% -$20.5M
BILL icon
7
BILL Holdings
BILL
$4.78B
$124M 1.18%
1,371,886
+823,986
+150% +$53.1M
NEWR
8
DELISTED
New Relic, Inc.
NEWR
$122M 1.17%
1,773,826
+1,073,846
+153% +$64.1M
TRU icon
9
TransUnion
TRU
$15.8B
$116M 1.11%
1,337,880
-245,095
-15% -$19.6M
CRL icon
10
Charles River Laboratories
CRL
$11.5B
$112M 1.07%
643,810
-90,040
-12% -$14.4M
TWLO icon
11
Twilio
TWLO
$29.3B
$112M 1.07%
510,980
+66,680
+15% +$10.7M
QTWO icon
12
Q2 Holdings
QTWO
$3.86B
$112M 1.06%
1,300,770
-41,823
-3% -$3.22M
LRCX icon
13
Lam Research
LRCX
$331B
$102M 0.97%
3,155,500
+478,500
+18% +$13M
CNC icon
14
Centene
CNC
$30.8B
$101M 0.97%
1,595,890
+102,100
+7% +$6.65M
CSGP icon
15
CoStar Group
CSGP
$12.3B
$101M 0.97%
1,426,200
+263,240
+23% +$17M
WCN
16
Waste Connections
WCN
$43.6B
$101M 0.97%
1,078,500
-32,600
-3% -$2.91M
AVLR
17
DELISTED
Avalara, Inc.
AVLR
$98M 0.93%
736,250
-501,615
-41% -$49.3M
IT icon
18
Gartner
IT
$11.2B
$93.7M 0.89%
772,300
-49,900
-6% -$5.77M
XLRN
19
DELISTED
Acceleron Pharma
XLRN
$93M 0.89%
976,420
-22,900
-2% -$2.21M
ZEN
20
DELISTED
ZENDESK INC
ZEN
$92.5M 0.88%
1,045,100
-31,175
-3% -$2.4M
EYE icon
21
National Vision
EYE
$1.78B
$92.3M 0.88%
3,022,620
+649,650
+27% +$17M
PCTY icon
22
Paylocity
PCTY
$7.8B
$91.3M 0.87%
626,110
-403,410
-39% -$46.9M
CLH icon
23
Clean Harbors
CLH
$17.5B
$89.6M 0.85%
1,493,905
+162,340
+12% +$9.05M
BJ icon
24
BJs Wholesale Club
BJ
$12.7B
$87.7M 0.84%
2,354,275
-512,325
-18% -$15.7M
CRWD icon
25
CrowdStrike
CRWD
$185B
$87.2M 0.83%
3,479,000
+485,396
+16% +$9.73M
1
2 3 4 5

Similar funds

VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $5.87B AUM 24.95% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return

TimesSquare Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, TimesSquare Capital Management held 245 positions worth $10.5B, up 25% from $8.39B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

TimesSquare Capital Management withdrew a net $429M in Q2 2020, closing 18 positions and reducing 125 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $56.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, TimesSquare Capital Management opened a new position in Immunomedics Inc worth $64.2M.

  • TimesSquare Capital Management's largest Q2 2020 buy was Immunomedics Inc: 1,811,000 shares worth $64.2M.
  • TimesSquare Capital Management added most to New Relic, Inc. in Q2 2020, an estimated $64.1M increase.
  • TimesSquare Capital Management's biggest Q2 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $120M.
  • TimesSquare Capital Management fully exited Alexion Pharmaceuticals in Q2 2020, selling an estimated $56.2M.
  • TimesSquare Capital Management's ten largest holdings make up 13% of its $10.5B portfolio in Q2 2020.
  • TimesSquare Capital Management opened 23 new positions and closed 18 in Q2 2020.
  • TimesSquare Capital Management's portfolio value rose 25% quarter-over-quarter to $10.5B.

Based on TimesSquare Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.